Renaissance Technologies - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 67 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 29.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,070
-2.9%
1,289,100
+11.6%
0.03%
+18.2%
Q2 2023$15,522
-14.1%
1,154,900
+5.9%
0.02%
-8.3%
Q1 2023$18,074
-21.1%
1,090,100
-11.5%
0.02%
-22.6%
Q4 2022$22,906
-99.9%
1,231,512
-44.7%
0.03%
-22.5%
Q3 2022$28,566,000
+295.0%
2,226,512
+115.8%
0.04%
+344.4%
Q2 2022$7,232,000
+147.1%
1,031,612
+192.1%
0.01%
+200.0%
Q1 2022$2,927,000
+2.2%
353,112
-16.5%
0.00%
-25.0%
Q4 2021$2,863,000
+933.6%
422,886
+709.5%
0.00%
Q3 2021$277,000
-90.3%
52,238
-92.9%
0.00%
-100.0%
Q1 2020$2,846,000
+331.9%
739,226
+320.7%
0.00%
+200.0%
Q4 2019$659,000
+14.2%
175,700
+15.0%
0.00%0.0%
Q3 2018$577,000
-84.7%
152,722
-90.1%
0.00%
-50.0%
Q2 2018$3,778,000
+13.8%
1,535,966
+10.5%
0.00%
-50.0%
Q1 2018$3,321,000
-23.8%
1,389,500
+24.7%
0.00%
-20.0%
Q4 2017$4,356,000
+197.1%
1,114,100
+91.6%
0.01%
+150.0%
Q3 2017$1,466,000
-40.4%
581,600
-34.8%
0.00%
-33.3%
Q2 2017$2,461,000
+229.9%
891,800
+133.2%
0.00%
+200.0%
Q1 2017$746,000
+4562.5%
382,400
+2449.3%
0.00%
Q3 2016$16,000
-92.2%
15,000
-91.5%
0.00%
Q1 2016$206,000
+123.9%
175,800
+728.2%
0.00%
Q1 2015$92,000
-85.9%
21,227
-89.2%
0.00%
-100.0%
Q3 2014$652,000
+54.5%
196,500
+41.9%
0.00%
+100.0%
Q3 2013$422,000138,5000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders